1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FAM184A CTRPv2 pan-cancer AAC -0.096 0.01
mRNA ARRDC2 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA ARSE CTRPv2 pan-cancer AAC 0.099 0.01
mRNA HSPA14 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA SWAP70 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA MAPKAPK2 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA SEC16B CTRPv2 pan-cancer AAC 0.089 0.01
mRNA DCAF8L2 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA STAP1 CTRPv2 pan-cancer AAC -0.097 0.01
mRNA NTF3 CTRPv2 pan-cancer AAC -0.092 0.01
Download CSV